The Framingham cardiovascular risk score in multiple sclerosis-Reference-Cited by-同舟云学术

The Framingham cardiovascular risk score in multiple sclerosis

Published:2015-04-27 Issue:8 Volume:22 Page:1176-1183
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Moccia M.¹,Lanzillo R.¹^ORCID,Palladino R.²³,Maniscalco G. T.¹⁴,De Rosa A.¹,Russo C.¹,Massarelli M.¹,Carotenuto A.¹,Postiglione E.¹,Caporale O.²,Triassi M.²,Brescia Morra V.¹

Affiliation:

1. Department of Neuroscience, Reproductive Science and Odontostomatology; Federico II University; Naples Italy

2. Department of Public Health; Federico II University; Naples Italy

3. Department of Primary Care and Public Health; Imperial College; London UK

4. Neurology Clinic; AORN ‘Antonio Cardarelli’; Naples Italy

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12720/fullpdf

Reference29 articles.

1. Epidemiology of multiple sclerosis: from risk factors to prevention;Ascherio;Semin Neurol,2008

2. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study;Roshanisefat;Eur J Neurol,2014

3. The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients;Sternberg;CNS Neurol Disord Drug Targets,2013

4. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study;Christiansen;Neuroepidemiology,2010

5. Risk of vascular disease in patients with multiple sclerosis: a review;Christiansen;Neurol Res,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbid onset of cardiovascular diagnosis and long-term confirmed disability progression in multiple sclerosis: A 15-year follow-up study;Journal of the Neurological Sciences;2024-09

2. An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience;Current Neuropharmacology;2024-08-15

3. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis;Neurology;2024-03-26

4. Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort;Neuroepidemiology;2024

5. Modelling Disease progression of Multiple Sclerosis in a South Wales Cohort;2023-09-15